FDA’s Critical Path Initiative: Opportunities for Metabolomics
Richard
D. Beger
Center
for Metabolomics
Division
of Systems Toxicology
National
Center for Toxicological Research
Jefferson,
AR 72079
Richard.Beger@fda.hhs.gov
2nd Metabolomics
Society Meeting
Boston,
MA
June 28,
2005
National
Center for Toxicological Research
